P. Couratier et al., NMDA ANTAGONIST BLOCKADE OF AT8-TAU IMMUNOREACTIVE CHANGES IN NEURONAL CULTURES, Fundamental and clinical pharmacology, 10(4), 1996, pp. 344-349
Antagonists at four distinct regulatory sites on the N-methyl-D-aspart
ate (NMDA) receptor were tested for their ability to attenuate NMDA-me
diated chronic excitotoxicity and the consequences on AT8 tau immunore
activity in neuronal cultures. Excitotoxicity was monitored in culture
s by diacetate fluorescein staining. Immunoreactivity of tau phosphory
lated at serine 202 was quantified by laser confocal microscopy. The N
MDA-receptor antagonists MK801, AP7 and 7-chlorokynurenate significant
ly blocked NMDA-induced cell death and significantly reduced AT8 tau i
mmunoreactivity. NMDA antagonism by the polyamine site antagonist, ife
nprodil, did not completely reverse the increase in AT8 tau immunolabe
ling induced by NMDA and did not completely protect NMDA-sensitive neu
rons, suggesting an heterogeneity in the NMDA receptor population.